BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 79 filers reported holding BICYCLE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $89,764 | -18.7% | 4,435 | 0.0% | 0.05% | -20.6% |
Q1 2024 | $110,432 | +37.7% | 4,435 | 0.0% | 0.07% | +15.3% |
Q4 2023 | $80,185 | -10.0% | 4,435 | 0.0% | 0.06% | -20.3% |
Q3 2023 | $89,099 | -17.6% | 4,435 | +4.7% | 0.07% | -8.6% |
Q2 2023 | $108,077 | +20.0% | 4,235 | 0.0% | 0.08% | +15.7% |
Q1 2023 | $90,078 | -28.1% | 4,235 | 0.0% | 0.07% | -26.3% |
Q4 2022 | $125,356 | +26.6% | 4,235 | 0.0% | 0.10% | +11.8% |
Q3 2022 | $99,000 | +39.4% | 4,235 | 0.0% | 0.08% | +49.1% |
Q2 2022 | $71,000 | -61.8% | 4,235 | 0.0% | 0.06% | -54.0% |
Q1 2022 | $186,000 | -29.3% | 4,235 | -2.1% | 0.12% | -25.7% |
Q4 2021 | $263,000 | +911.5% | 4,325 | +590.9% | 0.17% | +778.9% |
Q3 2021 | $26,000 | – | 626 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 917,218 | $40,248,000 | 48.61% |
GREAT POINT PARTNERS LLC | 550,592 | $24,160,000 | 5.84% |
Logos Global Management LP | 950,000 | $41,686,000 | 5.40% |
Deep Track Capital, LP | 1,855,993 | $81,441,000 | 5.22% |
First Light Asset Management, LLC | 890,174 | $39,061,000 | 3.44% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,154,126 | $50,643,000 | 3.00% |
Ikarian Capital, LLC | 478,784 | $21,009,000 | 2.76% |
Opaleye Management Inc. | 175,000 | $7,679,000 | 2.38% |
Frazier Life Sciences Management, L.P. | 603,521 | $26,483,000 | 2.26% |
Altium Capital Management LP | 120,000 | $5,266,000 | 1.76% |